Gaxos.ai Inc.
GXAI Nasdaq Services-Prepackaged Software Financials FY2022βFY2025
What Gaxos.ai Inc. does
No business description yet.
- Legal name
- GAXOS.AI INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 17, 2026
- Accession Β· CIK
- 0001213900-26-029223
0001895618
Revenue and margins
Gaxos.ai Inc. had $1.9M of revenue in fiscal 2025, up 48,225.0% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Gaxos.ai Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 299.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Gaxos.ai Inc. can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Cash and short-term investments | $0.7M | $3.6M | $14.4M | $0.8M |
| Current ratio | 3.5x | 13.5x | 41.9x | 18.5x |
| Quick ratio | 3.5x | 13.5x | 41.9x | 18.5x |
| Total assets | $0.9M | $3.7M | $17.0M | $13.4M |
| Total liabilities | $0.3M | $0.3M | $0.4M | $0.7M |
| Shareholders' equity | $0.7M | $3.4M | $16.6M | $13.1M |
| Net debt (β = net cash) | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Net income is positive | β | β | β | β |
| Cash from operations is positive | β | β | β | β |
| Return on assets rose | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β |
| Debt fell relative to assets | β | β | β | β |
| Current ratio rose | β | β | β | β |
| Share count didn't rise | β | β | β | β |
| Gross margin rose | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β |
| F-score | β / 3 | β / 6 | 4 / 7 | 2 / 7 |
| Accruals ratio | β17.1% | β41.7% | β1.3% | β0.3% |
| Altman Z'' | β7.94 | 7.26 | 46.67 | 20.53 |
4 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | β | $0.0M | $0.0M | $1.9M |
| Research and development | $0.8M | $0.9M | $1.0M | $1.0M |
| Operating income | β$1.4M | β$4.0M | β$3.7M | β$4.9M |
| Net income | β$1.4M | β$3.9M | β$3.4M | β$3.9M |
| Diluted EPS | β$1.64 | β$3.90 | β$1.92 | β$0.55 |
| Diluted shares | 0.00B | 0.00B | 0.00B | 0.01B |
| Cash flow | ||||
| Cash from operations | β$1.3M | β$3.0M | β$3.3M | β$3.9M |
| Stock-based compensation | β | $0.9M | $0.1M | $0.1M |
| Share buybacks | β | $0.1M | β | β |
| Dividends and buybacks | β | $0.1M | β | β |
| Balance sheet | ||||
| Cash and short-term investments | $0.7M | $3.6M | $14.4M | $0.8M |
| Current assets | $0.9M | $3.6M | $16.8M | $12.6M |
| Current liabilities | $0.3M | $0.3M | $0.4M | $0.7M |
| Property and equipment, net | β | $0.1M | $0.1M | $0.1M |
| Intangible assets | $0.1M | β | $0.1M | $0.7M |
| Total assets | $0.9M | $3.7M | $17.0M | $13.4M |
| Total liabilities | $0.3M | $0.3M | $0.4M | $0.7M |
| Shareholders' equity | $0.7M | $3.4M | $16.6M | $13.1M |
| Margins | ||||
| Operating margin | β | β1,338,433.3% | β92,590.0% | β254.3% |
| Net margin | β | β1,316,033.3% | β85,455.0% | β201.8% |
| Returns | ||||
| Return on capital employed | β207.7% | β117.2% | β22.3% | β38.6% |
| Return on equity | β207.3% | β192.0% | β34.1% | β26.2% |
| Return on assets | β151.0% | β170.3% | β33.0% | β25.6% |
| Return on tangible equity | β226.6% | β115.2% | β20.7% | β31.4% |
| Growth | ||||
| Revenue growth | β | β | 1,233.3% | 48,225.0% |
| Share count change | β | 13.8% | 79.9% | 299.1% |
| Financial health | ||||
| Current ratio | 3.5x | 13.5x | 41.9x | 18.5x |
| Quick ratio | 3.5x | 13.5x | 41.9x | 18.5x |
| Capital allocation | ||||
| Stock comp / revenue | β | 312,133.3% | 2,985.0% | 7.1% |
| Quality scores | ||||
| Piotroski F-score | β | β | 4.0 | 2.0 |
| Altman Z'' | β7.9 | 7.3 | 46.7 | 20.5 |
| Accruals ratio | β17.1% | β41.7% | β1.3% | β0.3% |
Source: SEC EDGAR XBRL filings (CIK 0001895618). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.